[DPHARMA] YoY Annualized Quarter Result on 31-Dec-2012 [#4]

Stock
[DPHARMA] DUOPHARMA BIOTECH BERHAD
Announcement Date
25-Feb-2013
Admission Sponsor
-
Sponsor
-
Financial Year
31-Dec-2012
Quarter
31-Dec-2012 [#4]
Profit Trend
QoQ- -2.53%
YoY- -2.59%
Quarter Report
Latest QR
Upcoming QR
DPHARMA's Result
DPHARMA's Financial Summary
View:
Show?
Annualized Quarter Result
31/12/15 31/12/14 31/12/13 31/12/12 31/12/11 31/12/10 31/12/09 CAGR
Revenue 270,680 176,961 162,405 135,310 138,132 131,437 123,766 13.92%
PBT 49,755 46,509 40,175 35,298 34,728 35,408 38,215 4.49%
Tax 0 0 -7,900 -9,284 -8,023 -6,739 -7,982 -
NP 49,755 46,509 32,275 26,014 26,705 28,669 30,233 8.65%
-
NP to SH 38,775 35,271 32,275 26,014 26,705 28,669 30,233 4.23%
-
Tax Rate 0.00% 0.00% 19.66% 26.30% 23.10% 19.03% 20.89% -
Total Cost 220,925 130,452 130,130 109,296 111,427 102,768 93,533 15.39%
-
Net Worth 270,177 192,942 181,850 169,354 163,783 156,881 142,975 11.18%
Dividend
31/12/15 31/12/14 31/12/13 31/12/12 31/12/11 31/12/10 31/12/09 CAGR
Div 15,843 25,679 24,293 19,434 24,983 222 24,985 -7.30%
Div Payout % 40.86% 72.81% 75.27% 74.71% 93.56% 0.77% 82.64% -
Equity
31/12/15 31/12/14 31/12/13 31/12/12 31/12/11 31/12/10 31/12/09 CAGR
Net Worth 270,177 192,942 181,850 169,354 163,783 156,881 142,975 11.18%
NOSH 278,959 138,807 138,817 138,815 138,799 138,832 138,810 12.33%
Ratio Analysis
31/12/15 31/12/14 31/12/13 31/12/12 31/12/11 31/12/10 31/12/09 CAGR
NP Margin 18.38% 26.28% 19.87% 19.23% 19.33% 21.81% 24.43% -
ROE 14.35% 18.28% 17.75% 15.36% 16.31% 18.27% 21.15% -
Per Share
31/12/15 31/12/14 31/12/13 31/12/12 31/12/11 31/12/10 31/12/09 CAGR
RPS 162.30 127.49 116.99 97.47 99.52 94.67 89.16 10.49%
EPS 19.17 25.41 23.25 18.74 19.24 20.65 21.78 -2.10%
DPS 9.50 18.50 17.50 14.00 18.00 0.16 18.00 -10.09%
NAPS 1.62 1.39 1.31 1.22 1.18 1.13 1.03 7.83%
Adjusted Per Share Value based on latest NOSH - 138,819
31/12/15 31/12/14 31/12/13 31/12/12 31/12/11 31/12/10 31/12/09 CAGR
RPS 28.14 18.40 16.88 14.07 14.36 13.66 12.87 13.91%
EPS 4.03 3.67 3.36 2.70 2.78 2.98 3.14 4.24%
DPS 1.65 2.67 2.53 2.02 2.60 0.02 2.60 -7.29%
NAPS 0.2809 0.2006 0.189 0.1761 0.1703 0.1631 0.1486 11.19%
Price Multiplier on Financial Quarter End Date
31/12/15 31/12/14 31/12/13 31/12/12 31/12/11 31/12/10 31/12/09 CAGR
Date 31/12/15 31/12/14 31/12/13 31/12/12 30/12/11 30/12/10 31/12/09 -
Price 2.62 2.50 2.58 2.13 2.02 2.39 2.40 -
P/RPS 1.61 1.96 2.21 2.19 2.03 2.52 2.69 -8.19%
P/EPS 11.27 9.84 11.10 11.37 10.50 11.57 11.02 0.37%
EY 8.87 10.16 9.01 8.80 9.52 8.64 9.08 -0.38%
DY 3.63 7.40 6.78 6.57 8.91 0.07 7.50 -11.38%
P/NAPS 1.62 1.80 1.97 1.75 1.71 2.12 2.33 -5.87%
Price Multiplier on Announcement Date
31/12/15 31/12/14 31/12/13 31/12/12 31/12/11 31/12/10 31/12/09 CAGR
Date 23/02/16 24/02/15 26/02/14 25/02/13 22/02/12 23/02/11 23/02/10 -
Price 2.61 2.92 2.60 2.17 2.12 2.45 2.33 -
P/RPS 1.61 2.29 2.22 2.23 2.13 2.59 2.61 -7.73%
P/EPS 11.23 11.49 11.18 11.58 11.02 11.86 10.70 0.80%
EY 8.91 8.70 8.94 8.64 9.08 8.43 9.35 -0.79%
DY 3.64 6.34 6.73 6.45 8.49 0.07 7.73 -11.79%
P/NAPS 1.61 2.10 1.98 1.78 1.80 2.17 2.26 -5.49%

PBT = Profit before Tax, NP = Net Profit, NP to SH = Net Profit Attributable to Shareholder, Div = Dividend, NP Margin = Net Profit Margin, ROE = Return on Equity, NOSH = Number of Shares, RPS = Revenue per Share, EPS = Earning Per Share, DPS = Dividend Per Share, NAPS = Net Asset Per Share, EOQ = End of Quarter, ANN = Announcement, P/RPS = Price/Revenue per Share, P/EPS = Price/Earning per Share, P/NAPS = Price/Net Asset per Share, EY = Earning Yield, DY = Dividend Yield.

NOSH is estimated based on the NP to SH and EPS. Div is an estimated figure based on the DPS and NOSH. Net Worth is an estimated figure based on the NAPS and NOSH.

Div Payout %, NP Margin, ROE, DY, QoQ ⃤ & YoY ⃤ figures in Percentage; RPS, EPS & DPS's figures in Cent; and NAPS's figures in Dollar.

All figures in '000 unless specified.

Discussions
Be the first to like this. Showing 0 of 0 comments
Post a Comment